Recent advancements within the field of diabetes treatment have brought about a promising class of medications known as GLP-1 and GIP receptor agonists. These agents offer a unique mechanism of action by enhancing the https://larissawwjw805241.mpeblog.com/69889343/novel-glp-1-and-gip-receptor-agonists-a-new-frontier-in-diabetes-treatment